Functional Evaluation of Platelet Aspirin Resistance after On-Pump Coronary Bypass Grafting Using Multiple Aggregation Tests

Abstract

Object: The predominant mechanism of early graft failure after coronary artery bypass grafting (CABG) is associated with antiplatelet treatment using drugs such as acetylsalicylic acid (ASA). Impaired hemostasis of multiple etiologies is often present in patients undergoing on-pump cardiac surgery. We investigated the impact of intravenous ASA administration on platelet function in this setting. Methods: Forty-two patients were enrolled in the study. Patients received 100 mg oral ASA once daily, beginning in the early postoperative period. Noncompliance was eliminated by the administration of 300 mg ASA intravenously at 6–8 days post-operation. Blood was drawn immediately before, 1 h and 24 h after ASA administration. Results: A platelet function analyzer (PFA-100™) was used to evaluate closure time (CT), turbidimetric platelet aggregation (TPA) and impedance platelet aggregation (IPA) induced by arachidonic acid (AA), collagen and ADP and results were compared with the respective values from 120 healthy individuals. At 1 h and 24 h after administration, we found that intravenous ASA caused CEPI-CT to be significantly prolonged with a reduction of AA and collagen-induced IPA. Despite postoperative oral ASA administration for 6–8 days, PFA-100™ CEPI and CADP-CT were significantly shorter and ADP-TPA and IPA values induced by any agonist were significantly greater in patients than in controls. Intravenous ASA had no significant influence on CADP-CT or ADP-induced IPA (ADP-IPA). Conclusion: Platelet tests for diagnosing patients as aspirin responders (ASA-R) or aspirin non-responders (ASA-NR) were found to be not comparable. Patients after CABG show augmented platelet dysfunction. Intravenous ASA administration may indicate a promising approach to reduce laboratory resistance after CABG procedure. The reason for this is not clear and requires additional clinical studies.

Key words

anticoagulation - pharmacology - coronary arteries bypass grafting - aspirin resistance - aspirin non-responder - platelet aggregometry

References

• 1 Seyfert U T, Haubelt H, Vogt A, Hellstern P. Variables influencing multiplate whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals.  Platelets. 2007;  18 199-206
• 2 Golanski J, Chlopicki S, Golanski R, Gresner P, Iwaszkiewicz A, Watala C. Resistance to aspirin in patients after coronary artery bypass grafting is transient.  Ther Drug Monit. 2005;  27 484-490
• 3 Yilmaz M B, Balbay Y, Caldir V et al. Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance.  Thromb Res. 2005;  115 25-29
• 4 Zimmermann N, Kurt M, Winter J et al. Aspirin-induced platelet inhibition in patients undergoing cardiac surgery.  Platelets. 2007;  18 528-534
• 5 Zimmermann N, Kurt M, Winter J, Gams E, Wenzel V, Hohlfeld T. Detection and duration of aspirin resistance after coronary artery bypass grafting.  J Thorac Cardiovasc Surg. 2008;  135 947-948
• 6 Mengistu A M, Wolf M W, Boldt J, Röhm K D, Lang J, Piper S N. Evaluation of a new platelet function analyzer in cardiac surgery: a comparison of modified thromboelastography and whole-blood aggregometry.  J Cardiothorac Vasc Anesth. 2008;  22 (1) 40-46
• 7 Gurbel P A, Bliden K P, DiChiara J et al. Evaluation of dose-related effects of aspirin on platelet function: results from the aspirin-induced platelet effect (ASPECT) study.  Circulation. 2007;  115 3156-3164
• 8 Patrono C, Coller B, FitzGerald G A, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  Chest. 2004;  126 234-264
• 9 [no authors listed]. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients.  BMJ. 2002;  324 71-86
• 10 Stein P D, Schunemann H J, Dalen J E, Gutterman D. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  Chest. 2004;  126 (Suppl. 3) 600S-608S
• 11 Zimmermann N, Kienzle P, Weber A A et al. Aspirin resistance after coronary artery bypass grafting.  J Thorac Cardiovasc Surg. 2001;  212 982-984
• 12 Zimmermann N, Wenk A, Kim U et al. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.  Circulation. 2003;  108 542-547
• 13 Hankey G J, Eikelboom J W. Aspirin resistance.  Lancet. 2006;  367 606-617
• 14 Tantry U S, Bliden K P, Gurbel P A. Resistance to antiplatelet drugs: current status and future research.  Expert Opin Pharmacother. 2005;  6 2027-2045
• 15 Cox D, Maree A O, Dooley R, Byrne M F, Fitzgerald D J. Effect of enteritic coating on antiplatelet activity of low-dose aspirin in healthy volunteers.  Stroke. 2006;  37 3153-3158
• 16 Dippel D W, Van Kooten F, Leebeck F W et al. What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke?.  Cerebrovasc Dis. 2004;  17 296-302
• 17 Lee P Y, Chen W H, Hg W et al. Low dose aspirin increases aspirin resistance in patients with coronary artery disease.  Am J Med. 2005;  118 723-727
• 18 MacDonald T M, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin.  Lancet. 2003;  361 573-574
• 19 Cornelissen J, Kirtland S, Lim E et al. Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function.  Thromb Haemost. 2006;  95 476-482
• 20 Hohlfeld T, Zimmermann N, Weber A A et al. Pyrazolinone analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis.  J Thromb Haemost. 2008;  6 (1) 166-173
• 21 Parolari A, Mussoni L, Frigerio M et al. Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery.  J Thorac Cardiovasc Surg. 2005;  130 (2) 303-308